These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 239966)

  • 1. Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.
    Lertora JJ; Mark AL; Johannsen J; Wilson WR; Abboud FM
    J Clin Invest; 1975 Sep; 56(3):719-24. PubMed ID: 239966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 4. Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat.
    Levy B
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):143-6. PubMed ID: 4147749
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of oral labetalol on forearm and hepatic circulations in normotensive humans.
    Sweeney MO; Cinquegrani M; Liang CS
    J Lab Clin Med; 1987 May; 109(5):589-94. PubMed ID: 3572208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific beta adrenergic blockade by practolol.
    Thompson ME; McDonald RH; Leon DF; Shaver JA
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):750-60. PubMed ID: 4154153
    [No Abstract]   [Full Text] [Related]  

  • 7. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of metoprolol, practolol, and propranolol after isoprenaline injections in asthmatic patients (author's transl)].
    Svedmyr N; Thiringer G
    Sem Hop; 1980 Apr 18-25; 56(15-16):798-804. PubMed ID: 6246620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
    Vincent HH; Boomsma F; Man in't Veld AJ; Derkx FH; Wenting GJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1984; 6(1):107-14. PubMed ID: 6199591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparable ergometric examinations before and after administration of practolol and bunitrolol (author's transl)].
    Pozenel H
    Wien Klin Wochenschr; 1975 Jan; 87(1):19-25. PubMed ID: 236621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):290-7. PubMed ID: 1002366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of practolol-induced beta1 adrenergic blockade in the canine heart.
    Hoskins EJ; Priola DV; Weiss GK
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):165-8. PubMed ID: 684274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta adrenergic blocking drugs and trifluperidol on intestinal motility and splanchnic nerve activity in cats.
    Szenohradszky J; Gibiszer PK; Pórszász J; Gács E
    Acta Chir Hung; 1983; 24(4):307-21. PubMed ID: 6670434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.